Atlas Trials

Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program

Clinical trial NCT03611582 · COMPLETED

Trial details

NCT number
NCT03611582
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
OverweightObesity
Start date
2018-08-01
Primary completion
2020-03-18
Enrollment
611

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.